Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain. Labradimil increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Molecular Weight:
1098.29
CAS Number:
[159768-75-9]
Formula:
C49H75N15O12S
Target:
Bradykinin Receptor
T27790
* VAT and and shipping costs not included. Errors and price changes excepted